Efforts to limit access to mifepristone have received a boost from a federal judge who took the bench during Trump's first term.

A new study shows a possible new abortion drug to replace mifepristone. But will these results increase abortion access—or restrict women's reproductive health options down the line?

A recent lightning rod for abortion opponents, the drug mifepristone—the first of two in the standard medication abortion regimen—surfaced several times during Robert F. Kennedy, Jr.’s first Senate confirmation hearing as President Trump’s pick for Health and Human Services secretary.

Mifepristone is under attack by abortion opponents, with several states seeking in federal court to restrict its use.

Idaho, Kansas and Missouri took up that banner ... state law enforcement.” Mifepristone was first approved in 2000, though the regulator changed the drug’s approved conditions and lowered ...

Robert F. Kennedy Jr. is back on Capitol Hill for a hearing before the Senate Health, Education, Labor and Pensions committee.

Missouri and Idaho officials say they have a separate ... the FDA to reinstate its restrictions on the medication, requiring mifepristone to be dispensed only in person and be used within the ...

Missouri, Kansas and Idaho say they have standing because they are incurring extra public insurance costs for care related to mifepristone. Missouri and Idaho officials claim allowing the pills to ...

A New York doctor has been indicted for prescribing the abortion pill in Louisiana. The state recently reclassified both mifepristone and misoprostol as “controlled dangerous substances.”

Robert F. Kennedy Jr. suggested, if confirmed to head the Department of Health and Human Services, he is open to significantly limiting access to mifepristone

Robert F. Kennedy Jr. was pressed to clarify his views on vaccines, abortion, and public health priorities in his first Senate hearing.

Country Financial and Chubb are among the best home insurance companies in Idaho. Many, or all, of the products featured on this page are from our advertising partners who compensate us when you ...